CVS Group plc (LON:CVSG) Stock Has Consensus Price Target of GBX 1,666.67

CVS Group plc (LON:CVSG) has received an average recommendation of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is GBX 1,666.67.

CVSG has been the subject of several analyst reports. Jefferies Financial Group reissued a “hold” rating and issued a GBX 1,400 target price on shares of CVS Group in a report on Friday, September 25th. Shore Capital Group reaffirmed a “hold” rating and set a GBX 1,400 price target on shares of CVS Group in a report on Thursday, September 24th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,000 price target on shares of CVS Group in a report on Thursday, September 24th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 1,700 price target on shares of CVS Group in a research report on Monday, July 27th.

CVS Group Stock Performance

Shares of CVSG opened at GBX 1,299 on Monday. The business has a 50-day simple moving average of GBX 1,268.16 and a two-hundred day simple moving average of GBX 1,235.43. The company has a quick ratio of 0.90, a current ratio of 1.18 and a debt-to-equity ratio of 110.41. CVS Group has a 52 week low of GBX 1,062 and a 52 week high of GBX 1,428. The stock has a market cap of £876.32 million, a price-to-earnings ratio of 53.46, a PEG ratio of 1.77 and a beta of 1.09.

CVS Group (LON:CVSG) last posted its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. On average, analysts expect that CVS Group will post 93.94 EPS for the current year.

Insider Activity

In other news, insider Joanne Shaw bought 1,592 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were bought at an average price of GBX 1,287 per share, for a total transaction of £20,489.04. Also, insider David Wilton bought 1,500 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were purchased at an average price of GBX 1,276 per share, for a total transaction of £19,140. Insiders have bought 3,860 shares of company stock worth $4,956,696 in the last three months. Company insiders own 1.48% of the company’s stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.